Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07635420 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing Intraoperative Indocyanine Green Fluorescence Imaging With Standard Clinical Assessment for Flap Perfusion in Head and Neck Reconstruction (VISION Trial)

Study acronym: VISION
StatusRecruiting
PhasePhase 4
Started2026-09-28
View on ClinicalTrials.gov ↗

Amendment history

2026-09-30
notable
Recruitment opened
146 trials monitored
See 5 trials at risk
This is a prospective multicentre randomised controlled trial evaluating whether intraoperative indocyanine green (ICG) fluorescence angiography improves outcomes in head and neck free flap reconstruction compared with standard clinical assessment of flap perfusion. Adult patients undergoing microvascular free flap reconstruction for oncologic, trauma, or benign head and neck defects will be randomised to either intraoperative ICG angiography or conventional clinical perfusion assessment. The primary outcome is partial flap loss requiring intervention within 30 days after surgery. Secondary outcomes include total flap loss, flap-related re-exploration, flap salvage, and postoperative complications.
Trial Details
NCT Number NCT07635420
Lead Sponsor Region Skane
Conditions Head and Neck Cancer (H&N), Free Tissue Flaps, Free Flap, Free Flap Evaluation, Indocyanine Green, Indocyanine Green (ICG), Microsurgery, Randomised Controlled Trial
Enrollment 244 participants
Start Date 2026-09-28
Primary Completion 2029-01-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-29